Synthesis of novel lactam derivatives and their evaluation as ligands for the dopamine receptors, leading to a D4-selective ligand

被引:24
作者
Awadallah, Fadi M.
Mueller, Franziska
Lehmann, Jochen
Abadi, Ashraf H. [1 ]
机构
[1] German Univ Cairo, Fac Pharm & Biotechnol, Dept Pharmaceut Chem, Cairo, Egypt
[2] Univ Jena, Inst Pharm Pharmaceut Med Chem, D-6900 Jena, Germany
[3] Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo, Egypt
关键词
dopamine ligands; arylpiperazines; cyclic amides; lactams; receptor selectivity;
D O I
10.1016/j.bmc.2007.06.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The preparation of some lactam (cyclic amide) derivatives bearing various phenylpiperazinylbutyl side chains attached to the amide nitrogen together with their dopamine receptor affinity study is described. The synthesis of the target compounds involved the preparation of the intermediate bromobutyl derivatives of the appropriate lactam followed by N-alkylation of the appropriate phenylpiperazines with these intermediates. Radioligand binding studies at D-2-D5 receptor subtypes and a functional calcium assay of the target compounds at D-2 and D-5 receptor subtypes were performed. All compounds, except 12a and 12b, showed selectivity towards the D-2-like receptor subtypes. Selectivity of the indolinone derivatives 11 a-d at the D-4 receptors was observed. Compound 11b exhibited a remarkable affinity to hD(4) receptors with K-i value of 0.04 +/- 0.02 nm and was > 43,000-fold selective over the hD(2) receptor. In the functional assay, all the active compounds were of antagonistic activity. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5811 / 5818
页数:8
相关论文
共 22 条
[11]   Dopamine/serotonin receptor ligands.: 10:: SAR studies on azecine-type dopamine receptor Ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist [J].
Hoefgen, B ;
Decker, M ;
Mohr, P ;
Schramm, AM ;
Rostom, SAF ;
El-Subbagh, H ;
Schweikert, PM ;
Rudolf, DR ;
Kassack, MU ;
Lehmann, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) :760-769
[12]   Pharmacological characterization of the benz[d]indolo[2,3-g]azecine LE300, a novel type of a nanomolar dopamine receptor antagonist [J].
Kassack, MU ;
Höfgen, B ;
Decker, M ;
Eckstein, N ;
Lehmann, J .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 366 (06) :543-550
[13]  
Kassack MU, 2002, J BIOMOL SCREEN, V7, P233
[14]   Biologically active 1-arylpiperazines.: Synthesis of new N-(4-aryl-1-piperazinyl)alkyl derivatives of quinazolidin-4(3H)-one, 2,3-dihydrophthalazine-1,4-dione and 1,2-dihydropyridazine-3,6-dione as potential serotonin receptor ligands [J].
Kowalski, P ;
Kowalska, T ;
Mokrosz, MJ ;
Bojarski, AJ ;
Charakchieva-Minol, S .
MOLECULES, 2001, 6 (09) :784-795
[15]   Azaindole derivatives with high affinity for the dopamine D4 receptor:: Synthesis, ligand binding studies and comparison of molecular electrostatic potential maps [J].
Löber, S ;
Hübner, H ;
Gmeiner, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (01) :97-102
[16]   Synthesis of 2-(5-bromo-2,3-dimethoxyphenyl)-5-(aminomethyl)1H-pyrrole analogues and their binding affinities for dopamine D2, D3, and D4 receptors [J].
Mach, RH ;
Huang, YS ;
Freeman, RA ;
Wu, L ;
Blair, S ;
Luedtke, RR .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (02) :225-233
[17]   Dopamine receptors: From structure to function [J].
Missale, C ;
Nash, SR ;
Robinson, SW ;
Jaber, M ;
Caron, MG .
PHYSIOLOGICAL REVIEWS, 1998, 78 (01) :189-225
[18]   Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents [J].
Newman, AH ;
Grundt, P ;
Nader, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (11) :3663-3679
[19]   CYCLIC BENZAMIDES AS MIXED DOPAMINE D-2 SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS - POTENTIAL ATYPICAL ANTIPSYCHOTIC AGENTS [J].
NORMAN, MH ;
RIGDON, GC ;
NAVAS, F ;
COOPER, BR .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (16) :2552-2563
[20]   Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agents [J].
Norman, MH ;
Navas, F ;
Thompson, JB ;
Rigdon, GC .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (24) :4692-4703